Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 809 results for "drl"

RANBAXY LABORATORIES : Loses Bid To Block Endo And DRL From La...

Following, and in response to, the revocation of Ranbaxy's tentative approvals for Ranbaxy's ANDAs for esomeprazole magnesium delayed-release capsules and valganciclovir hydrochloride tablets, Ranbaxy has filed a complaint against the U.S. Food and ... 4 Traders, 1 day ago

10 images for drl

MotorsportChannel.com, 1 week ago
MotorsportChannel.com, 1 week ago
Greentech Lead, 2 weeks ago
Citybizlist, 2 weeks ago
Style Bistro, 2 weeks ago
American Banking News, 3 weeks ago
WHIO TV, 4 weeks ago
India TV, 1 month ago
Sky Sports, 1 month ago
Times of India, 1 month ago

US FDA Conducts Inspection at DRL's Vizag facility

Looks like you are looking for a page that doesn't exist or has been moved. Please check the url to see if there are any mistakes or use the search box below to find the content you are looking for. If you still have difficulty finding what ...
 New Indian Express3 days ago

Buy Dr Reddys Labs; target of Rs 3750: Angel Broking

Angel Broking`s research report on Dr Reddys Labs For 2QFY2015, Dr Reddy's Laboratories (DRL) posted net sales of Rs3,587.9cr (V/s an expected Rs3,900cr), a yoy growth of 6.9% yoy. The growth was subdued as the US geography which is the company's ...
 Moneycontrol.com1 week ago Accumulate Dr Reddys Labs; target of Rs 3485: KRChoksey  Moneycontrol.com2 weeks ago Dr Reddy's Laboratories 2QFY2015 performance highlights and results update  Stock Markets Review3 weeks ago

Sensex, Nifty maintain uptrend; OBC, DRL fall post Q2 nos

Hindalco, Tata Motors, MM, Tata Steel and Infosys are top gainers in the Sensex. Among the losers are, BHEL, GAIL and Sun Pharma.
 Money Control3 weeks ago Sensex, Nifty weak; BHEL, Infosys, DRL, Hero shine  Money Control1 month ago Sensex rangebound; Infosys, Sun Pharma, TCS and DRL top losers  Economic Times1 month ago
Business Standard

US CONGRESS TO SET UP PROBE ON PRICE AGAINST INDIAN PHARMA FIRMS

The probe launched by the US legislature against Dr Reddy's Laboratories (DRL) and Sun Pharmaceuticals Industries Limited (Sun) of India over a steep increase in their drug prices in the US market is set to intensify. A panel formed ...
 Pharmacy Choice2 days ago US Congress steps up pressure for action on Sun Pharma, DRL  Business Standard India1 month ago DRL, Sun Pharma among 14 companies facing price probe in US  Times of India1 month ago DRL, Sun Pharma among 14 cos facing price probe in US  Times of India1 month ago
[x]  

Lack of US launches eats into DRL's Sept quarter profits

Pharma major Dr Reddy's Laboratories (DRL) has reported a 16.8% decline in its consolidated net profit to R574.10 crore in the September quarter compared to R690.25 crore a year earlier. The fall in profit was due to lack of new product launches in ...
 Financial Express3 weeks ago DR REDDY LABORATORIES : Lack of us launches eats into drl's sept quarter profits  4 Traders3 weeks ago DRL donates Rs 2 crs to Hudhud cyclone relief fund  Express Pharma1 month ago DRL sues ex-associate over non-compete deal  The Financial Chronicle1 month ago

Companies resort to Theory of Constraints to stay ahead in the game

Five years ago, Dr Reddy's Laboratories (DRL) was facing a difficult time in the US. It had a significant number of backorders and supplier ratings were at an all-time low. That's when the company started implementing processes advocated by the theory of ...
 Economic Times3 weeks ago

StanC boardstick: DRL, Infosys best, ITC weak, BPCL weakest

Rahul Singh of StanChart Securities says there are companies with strong managements but low scoring boards like ITC, Idea and Larsen Toubro. The companies with the lowest board scores are BPCL, Prestige, IOC, SAIL and JP Associates. The companies with the ...
 Money Control2 weeks ago

DRL may file new drug applications with FDA within year

Pic Courtesy: - Hyderabad: Drug maker Dr Reddy's Laboratories has said it may file two new drug applications (NDA) with the US Food and Drug Authority (FDA) by the end of next year. Chief Operating Officer and Member of the Management Council, DRL, ...
 ZeeNews.com2 weeks ago Dr Reddy's Lab's Visakhapatnam unit comes under USFDA lens  Financial Express3 days ago Dr Reddy's May File New Drug Applications With US Regulator by 2015-End  NDTV Profit2 weeks ago Dr Reddy's Laboratories may file new drug applications with FDA within year  Economic Times2 weeks ago
[x]  

Novartis Drags DRL to Court over Gleevec

HYDERABAD: Basel-headquartered Novartis Pharmaceuticals Corporation and Novartis AG dragged city-based Dr Reddy's Laboratories Ltd (DRL) and its US subsidiary Dr Reddy's Laboratories Inc to the US court over alleged patent infringement. As per ...
 New Indian Express1 month ago DRL, Aurobindo Dragged to US Court Over Patents  New Indian Express2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less